Fertility Services Market Size, Share, Growth, and Industry Analysis, By Type (Male Infertility,Female Infertility), By Application (Fertility Clinics,Hospitals,Surgical Centers,Clinical Research Institutes), Regional Insights and Forecast to 2035

Fertility Services Market Overview

The global Fertility Services Market size is projected to grow from USD 58683.08 million in 2026 to USD 71235.4 million in 2027, reaching USD 335915.63 million by 2035, expanding at a CAGR of 21.39% during the forecast period.

The fertility services market has become one of the fastest-growing healthcare service industries globally, driven by increasing infertility rates among both men and women. Approximately 17.5% of adults worldwide experience infertility, with 48 million couples and 186 million individuals affected, according to WHO data. In 2022, over 2.5 million in-vitro fertilization (IVF) cycles were performed worldwide, leading to the birth of more than 500,000 babies annually. Globally, more than 9% of men and 11% of women of reproductive age face fertility-related challenges, which creates a substantial demand for assisted reproductive technologies (ART).

The United States fertility services market report highlights that around 9% of men and 11% of women of reproductive age experience fertility problems. Approximately 300,000 assisted reproductive technology cycles are performed annually across the country, resulting in over 90,000 births. In 2022, the Centers for Disease Control and Prevention (CDC) reported that about 2.1% of all infants born in the U.S. were conceived using ART. With more than 450 fertility clinics operating across 50 states, the U.S. accounts for nearly 15% of global ART procedures.

What is Fertility Services?

Fertility services are medical treatments and procedures designed to help individuals and couples overcome infertility and achieve pregnancy. These services include in-vitro fertilization (IVF), fertility testing, egg and sperm preservation, embryo transfer, genetic screening, and other assisted reproductive technologies (ART). Growing infertility rates and delayed parenthood have significantly increased the demand for these specialized healthcare services.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 64% of demand arises from rising infertility linked to obesity, PCOS, and delayed pregnancies, significantly expanding assisted reproductive technology adoption.
• Major Market Restraint: 41% of patients face affordability issues due to high IVF costs, limited insurance support, and multiple required treatment cycles worldwide.
• Emerging Trends: 52% of fertility clinics worldwide now integrate artificial intelligence tools for embryo selection, increasing pregnancy prediction accuracy and improving clinical decision-making processes.
• Regional Leadership: Europe contributes 55% of total ART cycles annually, maintaining dominance, followed by North America with 24% global share in fertility services.
• Competitive Landscape: The top five players collectively control 38% of global fertility services market share, highlighting moderate consolidation and competitive intensity.
• Market Segmentation: Female infertility treatments represent 62% share of fertility services demand globally, while male infertility services account for the remaining 38% segment.
• Recent Development: 47% of fertility centers worldwide introduced cryopreservation and preimplantation genetic testing since 2023, enhancing treatment outcomes and patient adoption significantly.

Fertility Services Market Latest Trends

The fertility services market analysis highlights several key trends shaping industry growth. One of the most notable trends is the rapid increase in elective egg freezing, which has grown by 1,500% in the U.S. over the last decade. Globally, more than 150,000 women undergo egg freezing annually, representing a major fertility services market opportunity. Another trend is the integration of artificial intelligence in embryo selection, with over 50% of clinics adopting AI-powered imaging tools to improve implantation success rates.

The fertility services industry report also emphasizes the growing importance of genetic testing, with preimplantation genetic testing (PGT) used in more than 35% of IVF cycles in advanced markets. Demand for surrogacy services is also rising, with an estimated 20,000 surrogacy births globally each year. Additionally, telehealth adoption has increased, with nearly 40% of fertility consultations conducted virtually in 2023. Fertility services market insights further show that Asia-Pacific is emerging as a cost-effective destination, with treatment costs nearly 60% lower than in North America and Europe, driving cross-border fertility tourism.

Fertility Services Market Dynamics

DRIVER

"Rising demand for assisted reproductive technologies (ART)."

The fertility services market growth is largely driven by the rising demand for ART treatments. Globally, over 2.5 million ART cycles are performed annually, with more than 500,000 successful births. Female infertility, affecting 11% of women of reproductive age, and male infertility, impacting 7% of men, are key demand drivers. Rising maternal age is a significant factor, as the average age of first-time mothers has increased to 30.9 years in developed countries. In addition, the fertility services market outlook highlights that nearly 40% of infertility cases involve combined male and female factors, making ART services critical to achieving conception.

RESTRAINT

"High cost of treatment procedures."

One of the major fertility services market restraints is the high cost associated with ART procedures. On average, a single IVF cycle costs between $12,000–$15,000 in the U.S., while additional services like genetic testing can increase costs by 30–40%. Around 41% of patients cite affordability as a barrier to treatment, while less than 25% of global healthcare systems provide full insurance coverage for fertility services. Fertility services market insights reveal that more than 70% of patients in emerging economies cannot access ART due to financial constraints, creating disparities in availability.

OPPORTUNITY

"Expansion of fertility preservation services."

The fertility services market opportunities are expanding with the growing popularity of fertility preservation services. Globally, elective egg freezing procedures have grown from fewer than 10,000 annually in 2010 to more than 150,000 in 2023. Cancer-related fertility preservation is also rising, as more than 20% of cancer survivors are under 40 years old and seek to preserve reproductive potential. The fertility services industry analysis indicates that cryopreservation services are projected to account for more than 25% of ART procedures by 2025. Fertility tourism in Asia-Pacific, where costs are 50–60% lower, also presents substantial opportunities.

CHALLENGE

"Limited success rates and multiple cycle requirements."

The fertility services market faces challenges related to treatment success rates. The average success rate of IVF is 35–40% per cycle, requiring many patients to undergo multiple attempts. Nearly 60% of couples need more than one cycle to achieve pregnancy, which significantly increases financial and emotional stress. Additionally, success rates decline with age, with women over 40 experiencing only 10–15% success rates per cycle. Fertility services market insights show that 45% of patients discontinue treatment due to repeated failures, highlighting the need for technological innovation to improve outcomes.

Why is Demand Increasing for Fertility Services?

Demand for fertility services is increasing due to rising infertility rates, delayed pregnancies, lifestyle-related health conditions, and greater awareness of assisted reproductive technologies. Factors such as obesity, PCOS, stress, and increasing maternal age have contributed to fertility challenges among both men and women. Additionally, growing acceptance of fertility treatments and fertility preservation options continues to drive industry growth.

Fertility Services Market Segmentation

The Fertility Services Market is segmented by type and application, reflecting the increasing demand for assisted reproductive technologies and infertility treatment solutions. Fertility Services Market Analysis indicates that infertility affects approximately 1 in 6 adults globally during their reproductive years, creating substantial demand for fertility diagnosis and treatment services. Male infertility and female infertility constitute the primary type segments, while fertility clinics, hospitals, surgical centers, and clinical research institutes represent the major application categories. Fertility Services Market Research Report findings highlight increasing utilization of in vitro fertilization procedures, fertility preservation techniques, genetic screening technologies, and reproductive health services across both developed and emerging healthcare markets.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Male Infertility

Male infertility represents a significant segment of the Fertility Services Market, with male-related factors contributing to nearly 40% of infertility cases worldwide. Common conditions include low sperm count, poor sperm motility, hormonal disorders, and genetic abnormalities. Fertility evaluations frequently include semen analysis, hormone testing, and reproductive imaging procedures to identify underlying causes.

Advancements in assisted reproductive technologies have improved treatment outcomes for male infertility patients. Techniques such as intracytoplasmic sperm injection and sperm retrieval procedures are increasingly utilized in fertility treatment programs. Fertility Services Market Trends indicate growing awareness of male reproductive health, increasing diagnosis rates, and greater acceptance of fertility treatment options among couples seeking conception assistance.

Female Infertility

Female infertility accounts for a substantial portion of fertility treatment demand, with female-related factors contributing to approximately 50% of infertility cases globally. Common causes include ovulation disorders, endometriosis, polycystic ovary syndrome, uterine abnormalities, and age-related fertility decline. Fertility specialists increasingly utilize advanced diagnostic procedures to evaluate reproductive health and treatment eligibility.

The average maternal age at first childbirth continues to rise in many countries, increasing the demand for fertility services and assisted reproductive technologies. Egg freezing, ovarian stimulation protocols, embryo transfer procedures, and genetic screening services are becoming more common. Fertility Services Market Outlook indicates that delayed parenthood trends and rising infertility prevalence continue supporting long-term demand for female fertility treatments.

BY APPLICATION

Fertility Clinics

Fertility clinics represent the largest application segment within the Fertility Services Market due to their specialization in reproductive medicine and assisted conception procedures. Thousands of fertility clinics operate globally, offering services including IVF, ICSI, fertility preservation, donor programs, and genetic testing. Many clinics perform hundreds to thousands of treatment cycles annually.

Specialized fertility clinics often achieve higher procedural volumes and treatment expertise compared to general healthcare facilities. Technological advancements in embryo monitoring, laboratory automation, and reproductive diagnostics continue enhancing clinical outcomes. Fertility Services Market Insights indicate that fertility clinics remain the primary point of care for infertility diagnosis and treatment worldwide.

Hospitals

Hospitals play a critical role in the Fertility Services Market by integrating reproductive medicine services within broader healthcare systems. Large hospitals frequently operate dedicated fertility departments equipped with advanced laboratories, surgical suites, and multidisciplinary medical teams. These facilities support both routine fertility treatments and complex reproductive health cases.

Hospitals provide access to comprehensive patient care, including gynecology, endocrinology, urology, and maternal health services. Increasing investment in reproductive healthcare infrastructure has expanded hospital-based fertility programs in numerous countries. Fertility Services Market Forecast assessments indicate continued growth in hospital fertility services due to increasing patient demand and expanding healthcare access.

Surgical Centers

Surgical centers contribute significantly to fertility treatment delivery through specialized reproductive procedures and minimally invasive interventions. Common procedures include laparoscopic surgery, hysteroscopy, sperm retrieval techniques, and reproductive tract corrective surgeries. These interventions help address structural and physiological factors affecting fertility.

Technological advancements have improved procedural safety, reduced recovery times, and enhanced treatment effectiveness. Many fertility patients undergo outpatient surgical procedures before commencing assisted reproductive treatments. Fertility Services Market Growth is supported by increasing utilization of fertility-related surgical interventions and expanding access to specialized reproductive care facilities.

Clinical Research Institutes

Clinical research institutes support the Fertility Services Market through innovation, treatment development, and reproductive health research programs. These institutions conduct studies involving embryo development, fertility preservation, genetic screening, reproductive endocrinology, and assisted reproductive technologies. Numerous clinical trials are ongoing globally to improve treatment outcomes and patient success rates.

Research institutes collaborate with fertility clinics, hospitals, biotechnology companies, and academic centers to advance reproductive medicine. Emerging technologies including artificial intelligence, genomic analysis, and personalized fertility treatment approaches continue gaining research attention. Fertility Services Market Opportunities remain substantial as scientific advancements contribute to improved fertility treatment effectiveness and broader patient accessibility.

Which Segment is Growing Faster?

The Female Infertility segment is growing the fastest and accounts for the largest share of fertility service demand. Growth is driven by increasing cases of ovulatory disorders, PCOS, delayed pregnancies, and rising adoption of assisted reproductive technologies. Fertility Clinics also represent the leading application segment due to their specialized expertise, advanced laboratory facilities, and high volume of IVF procedures performed globally.

Fertility Services Market Regional Outlook

The Fertility Services Market demonstrates strong regional variation driven by infertility prevalence, healthcare infrastructure, reproductive awareness, and access to assisted reproductive technologies. North America accounts for approximately 38% of the global market share due to advanced fertility treatment availability and high utilization rates. Europe represents nearly 30%, supported by favorable healthcare systems and increasing fertility treatment adoption. Asia-Pacific contributes approximately 25%, benefiting from large patient populations and expanding reproductive healthcare investments. Middle East & Africa account for around 7%, supported by improving healthcare access and rising infertility awareness. Fertility Services Market Analysis indicates that demographic changes and delayed parenthood trends continue influencing regional demand patterns.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

NORTH AMERICA

North America holds approximately 38% of the Fertility Services Market share, supported by advanced reproductive healthcare infrastructure, widespread availability of assisted reproductive technologies, and high treatment adoption rates. The region performs hundreds of thousands of fertility treatment cycles annually through specialized fertility clinics, hospitals, and reproductive medicine centers. Increasing infertility prevalence, delayed parenthood trends, and growing awareness of fertility preservation services continue driving demand. Fertility Services Market Analysis indicates strong utilization of IVF, genetic testing, embryo freezing, and donor programs throughout the region.

Technological innovation remains a key growth factor across North America. Fertility providers increasingly utilize artificial intelligence-assisted embryo selection, advanced laboratory systems, and digital patient management platforms to improve treatment outcomes. Expanding employer-sponsored fertility benefits, rising investments in reproductive healthcare facilities, and increasing acceptance of fertility treatments continue supporting market expansion. Fertility Services Market Outlook suggests sustained demand for personalized fertility solutions and fertility preservation services.

EUROPE

Europe accounts for nearly 30% of the Fertility Services Market and benefits from strong healthcare systems, advanced fertility clinics, and extensive reproductive medicine expertise. Countries including Spain, Germany, France, Italy, and the United Kingdom conduct significant volumes of fertility procedures each year. Rising infertility rates, delayed family formation, and increasing awareness of assisted reproductive technologies continue supporting market demand across the region.

Research and innovation play a significant role in European market development. Fertility centers increasingly implement genetic screening technologies, advanced embryo culture techniques, and laboratory automation systems. Cross-border fertility treatment activity remains an important contributor to patient volumes. Fertility Services Market Research Report findings indicate that ongoing healthcare investments and reproductive health awareness programs continue strengthening regional market performance.

ASIA-PACIFIC

Asia-Pacific represents approximately 25% of the Fertility Services Market, driven by large patient populations, expanding healthcare infrastructure, and increasing demand for fertility treatments. Countries such as China, India, Japan, South Korea, and Australia continue expanding fertility clinic networks and reproductive healthcare services. Urbanization, delayed marriages, and changing lifestyle patterns contribute significantly to rising infertility treatment demand throughout the region.

Healthcare providers are investing in modern fertility laboratories, fertility preservation programs, and advanced assisted reproductive technologies. Medical tourism also contributes to market growth in several countries that offer specialized fertility services. Fertility Services Market Insights indicate that improving healthcare accessibility and rising awareness of reproductive treatment options will continue supporting long-term market expansion across Asia-Pacific.

MIDDLE EAST & AFRICA

Middle East & Africa hold around 7% of the Fertility Services Market, supported by improving healthcare infrastructure, rising infertility awareness, and increasing investments in specialized fertility treatment facilities. Several countries have expanded reproductive healthcare capabilities through the establishment of advanced fertility clinics and IVF centers. Growing demand for fertility treatments continues to support service expansion throughout the region.

Healthcare modernization programs, physician training initiatives, and adoption of advanced reproductive technologies are strengthening treatment accessibility across Middle East & Africa. Fertility clinics increasingly offer fertility preservation, genetic testing, and assisted reproductive procedures to address evolving patient needs. Fertility Services Market Forecast assessments indicate continued development opportunities as healthcare access improves and reproductive health awareness increases.

Which Region Dominates the Industry?

Europe dominates the fertility services industry, accounting for the largest share of global assisted reproductive technology cycles. The region benefits from a strong network of fertility clinics, advanced healthcare infrastructure, supportive regulations, and high adoption of fertility treatments. Countries such as Germany, the United Kingdom, France, and Spain are among the leading contributors to the region's market leadership.

List of Top Fertility Services Companies

• Esco Micro Pte. Ltd
• Virtus Health Ltd.
• INVO Bioscience Inc
• Anecova SA
• Instituto Bernabeu SL
• The Cooper Companies Inc.
• Monash IVF Group Ltd.
• Vitrolife AB
• Merck KGaA
• CRITEX GmbH

Top Two Companies with Highest Market Share:

• Vitrolife AB holds approximately 15% market share globally, specializing in laboratory solutions and media for ART.
• The Cooper Companies Inc. maintains around 13% share, focusing on fertility equipment, diagnostics, and consumables.

Investment Analysis and Opportunities

The fertility services market research report indicates strong investment activity. Globally, more than $2 billion has been invested in fertility start-ups and technologies since 2020. Fertility preservation services, including egg and sperm freezing, present a major investment opportunity, with more than 150,000 procedures annually. Cross-border fertility tourism is another attractive area, as more than 30% of patients in Europe travel across countries for lower-cost or faster treatments.

Venture capital investments have supported AI-powered embryo selection technologies, with adoption expected to rise above 60% by 2025. Fertility benefits offered by large employers, such as coverage of ART treatments, are increasing demand, as over 40% of Fortune 500 companies now provide such benefits. The fertility services industry outlook suggests significant opportunities in emerging regions such as Asia-Pacific, where treatment affordability and rising awareness are expanding patient access.

New Product Development

The fertility services market is experiencing rapid innovations. Vitrolife AB launched next-generation embryo culture media in 2023, improving implantation success rates by 15%. The Cooper Companies introduced advanced ICSI needles with enhanced precision, adopted in more than 500 clinics globally. Artificial intelligence-powered embryo imaging solutions, such as time-lapse monitoring, are now used in 52% of clinics worldwide.

Cryopreservation technologies have advanced, enabling longer storage of eggs and sperm without loss of viability, with over 1 million samples currently stored globally. Genetic testing innovations allow detection of over 200 chromosomal abnormalities, improving live birth rates by 20% in high-risk patients. Fertility services market insights highlight that clinical research institutes are actively developing minimally invasive procedures, with more than 200 ongoing trials worldwide.

Five Recent Developments

• Vitrolife AB launched upgraded cryopreservation kits in 2024, increasing embryo survival rates by 12%.
• The Cooper Companies expanded its fertility consumables portfolio in 2023, reaching over 80 countries.
• Monash IVF Group introduced AI-based embryo assessment in 2024, improving pregnancy prediction accuracy by 18%.
• Merck KGaA launched fertility lab automation systems in 2025, reducing lab error rates by 25%.
• Virtus Health Ltd. opened three new fertility centers in Asia-Pacific in 2023, expanding capacity by 20%.

Report Coverage of Fertility Services Market

The fertility services market research report provides comprehensive coverage of global trends, segmentation, regional insights, and competitive landscape. The report covers data on infertility prevalence, with 48 million couples and 186 million individuals affected globally. It analyzes ART procedures, with more than 2.5 million IVF cycles annually and over 500,000 births.

The fertility services industry report evaluates drivers such as rising maternal age, with the average age of first-time mothers exceeding 30 years in developed countries. It also assesses challenges like success rates of only 35–40% per IVF cycle. Segmentation analysis includes male infertility, affecting 30 million men, and female infertility, impacting 10% of reproductive-age women. Regional analysis shows Europe leading with 55% of global ART cycles, while Asia-Pacific grows rapidly with over 400,000 annual cycles.

The report also highlights the role of leading companies such as Vitrolife AB and The Cooper Companies, which together hold nearly 28% of global share. It further provides fertility services market insights into investments exceeding $2 billion in fertility start-ups since 2020, as well as opportunities in AI-powered embryo selection, cryopreservation, and fertility tourism.

Fertility Services Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 58683.08 Million in 2026
Market Size Value By	USD 335915.63 Million by 2035
Growth Rate	CAGR of 21.39% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Male Infertility Female Infertility By Application : Fertility Clinics Hospitals Surgical Centers Clinical Research Institutes
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample